{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:22:07Z","timestamp":1787948527815,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.conctc.2026.101660","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:55:39Z","timestamp":1781884539000},"page":"101660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial"],"prefix":"10.1016","volume":"52","author":[{"given":"Atul","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8812-8751","authenticated-orcid":false,"given":"Daniel J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-9539","authenticated-orcid":false,"given":"Vaishnavi","family":"Kundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Woehrle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatro","family":"Chakladar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-4984","authenticated-orcid":false,"given":"Livia","family":"Firmino Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.conctc.2026.101660_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00043.2008","article-title":"Pathophysiology of sleep apnea","volume":"90","author":"Dempsey","year":"2010","journal-title":"Physiol. Rev."},{"issue":"9918","key":"10.1016\/j.conctc.2026.101660_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(13)60734-5","article-title":"Adult obstructive sleep apnoea","volume":"383","author":"Jordan","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.conctc.2026.101660_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"9","key":"10.1016\/j.conctc.2026.101660_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.conctc.2026.101660_bib5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea: a population health perspective","volume":"165","author":"Young","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.conctc.2026.101660_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/resp.13838","article-title":"Global burden of sleep-disordered breathing and its implications","volume":"25","author":"Lyons","year":"2020","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.conctc.2026.101660_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1513\/pats.200708-119MG","article-title":"Adherence to continuous positive airway pressure therapy: the challenge to effective treatment","volume":"5","author":"Weaver","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"12","key":"10.1016\/j.conctc.2026.101660_bib8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.5664\/jcsm.11858","article-title":"Treatment of central sleep apnea in adults: an American academy of sleep medicine clinical practice guideline","volume":"21","author":"Badr","year":"2025","journal-title":"J. Clin. Sleep Med."},{"issue":"15","key":"10.1016\/j.conctc.2026.101660_bib9","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","article-title":"Obstructive sleep apnea in adults","volume":"380","author":"Veasey","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.conctc.2026.101660_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/15402000701264005","article-title":"How early in treatment is pap adherence established? Revisiting night-to-night variability","volume":"5","author":"Aloia","year":"2007","journal-title":"Behav. Sleep Med."},{"issue":"8","key":"10.1016\/j.conctc.2026.101660_bib11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cpr.2008.07.004","article-title":"Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention","volume":"28","author":"Olsen","year":"2008","journal-title":"Clin. Psychol. Rev."},{"issue":"2","key":"10.1016\/j.conctc.2026.101660_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5935\/1984-0063.20170010","article-title":"Acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea (Osa) in a Southeast Asian privately funded healthcare system","volume":"10","author":"Lee","year":"2017","journal-title":"Sleep Sci."},{"issue":"6","key":"10.1016\/j.conctc.2026.101660_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smrv.2011.01.003","article-title":"A systematic review of cpap adherence across age groups: clinical and empiric insights for developing cpap adherence interventions","volume":"15","author":"Sawyer","year":"2011","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"10.1016\/j.conctc.2026.101660_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjoto.2018.05.012","article-title":"Adherence to continuous positive airway pressure therapy in Singaporean patients with obstructive sleep apnea","volume":"39","author":"Tan","year":"2018","journal-title":"Am. J. Otolaryngol."},{"issue":"24","key":"10.1016\/j.conctc.2026.101660_bib15","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa1306187","article-title":"Cpap, weight loss, or both for obstructive sleep apnea","volume":"370","author":"Chirinos","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.conctc.2026.101660_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1606599","article-title":"Cpap for prevention of cardiovascular events in obstructive sleep apnea","volume":"375","author":"McEvoy","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.conctc.2026.101660_bib17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.06.00107805","article-title":"Increased incidence of coronary artery disease in sleep apnoea: a long-term Follow-Up","volume":"28","author":"Peker","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"13","key":"10.1016\/j.conctc.2026.101660_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.conctc.2026.101660_bib19","series-title":"Injection, for Subcutaneous Use. Us Prescribing Information","year":"2024"},{"issue":"3","key":"10.1016\/j.conctc.2026.101660_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.conctc.2026.101660_bib21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/PPA.S463354","article-title":"Preference for a novel oral alternative to parenterally administered medications","volume":"18","author":"Myers","year":"2024","journal-title":"Patient Prefer. Adherence"},{"issue":"11","key":"10.1016\/j.conctc.2026.101660_bib22","article-title":"Small-molecule Glp-1 receptor agonists: a promising pharmacological approach","volume":"61","author":"\u0218eremet","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"10522","key":"10.1016\/j.conctc.2026.101660_bib23","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/S0140-6736(25)02381-5","article-title":"Oral small-molecule Glp-1 receptor agonist for type 2 diabetes and obesity","volume":"406","author":"Chow","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.conctc.2026.101660_bib24","series-title":"Tablets, for Oral Use. Us Prescribing Information","year":"2026"},{"issue":"8","key":"10.1016\/j.conctc.2026.101660_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"Glp-1-Based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10400","key":"10.1016\/j.conctc.2026.101660_bib26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(23)01302-8","article-title":"Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"issue":"10522","key":"10.1016\/j.conctc.2026.101660_bib31","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0140-6736(25)02165-8","article-title":"Orforglipron, an oral small-molecule Glp-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (Attain-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial","volume":"406","author":"Horn","year":"2026","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.conctc.2026.101660_bib32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule Glp-1 receptor agonist, in early type 2 diabetes","volume":"393","author":"Rosenstock","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.conctc.2026.101660_bib33","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an oral small-molecule Glp-1 receptor agonist for obesity treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.conctc.2026.101660_bib34","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: a review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.conctc.2026.101660_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sleep.2024.06.014","article-title":"Weight reduction and the impact on apnea-hypopnea index: a systematic meta-analysis","volume":"121","author":"Malhotra","year":"2024","journal-title":"Sleep Med."},{"issue":"6 Pt 1","key":"10.1016\/j.conctc.2026.101660_bib36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7326\/0003-4819-103-6-850","article-title":"Weight loss in mildly to moderately Obese patients with obstructive sleep apnea","volume":"103","author":"Smith","year":"1985","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.conctc.2026.101660_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.201903-0692OC","article-title":"Effect of weight loss on upper airway anatomy and the apnea-hypopnea index. The importance of tongue fat","volume":"201","author":"Wang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.conctc.2026.101660_bib39","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American heart association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.conctc.2026.101660_bib40","first-page":"1","article-title":"Pharmacokinetic bioequivalence of orforglipron tablets and capsules in healthy participants with obesity or overweight","author":"Ma","year":"2026","journal-title":"Diabetes Obes. Metabol."},{"issue":"Suppl 1","key":"10.1016\/j.conctc.2026.101660_bib41","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.21037\/jtd.2017.12.142","article-title":"Physiological consequences of cpap therapy withdrawal in patients with obstructive sleep Apnoea-an opportunity for an efficient experimental model","volume":"10","author":"Schwarz","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.conctc.2026.101660_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.sleep.2020.12.044","article-title":"Endorsement of: \"clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: an American Academy of Sleep Medicine Clinical Practice Guideline\" by the world sleep society","volume":"79","author":"Hamilton","year":"2021","journal-title":"Sleep Med."},{"key":"10.1016\/j.conctc.2026.101660_bib43","series-title":"Aasm Clarifies Hypopnea Scoring Criteria","year":"2013"},{"issue":"5","key":"10.1016\/j.conctc.2026.101660_bib44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.5664\/jcsm.2172","article-title":"Rules for scoring respiratory events in sleep: update of the 2007 aasm manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine","volume":"8","author":"Berry","year":"2012","journal-title":"J. Clin. Sleep Med."},{"issue":"14","key":"10.1016\/j.conctc.2026.101660_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/eurheartj\/ehy624","article-title":"The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study","volume":"40","author":"Azarbarzin","year":"2019","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.conctc.2026.101660_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.chest.2020.03.053","article-title":"The sleep apnea-specific hypoxic burden predicts incident heart failure","volume":"158","author":"Azarbarzin","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.conctc.2026.101660_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.202209-1808OC","article-title":"Sleep apnea physiological burdens and cardiovascular morbidity and mortality","volume":"208","author":"Labarca","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.conctc.2026.101660_bib48","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00828-2023","article-title":"Hypoxic burden to guide cpap treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the isaacc trial","volume":"62","author":"Pinilla","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.conctc.2026.101660_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/rccm.201707-1435OC","article-title":"Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea","volume":"197","author":"Sands","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.conctc.2026.101660_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx183","article-title":"Quantifying the arousal threshold using polysomnography in obstructive sleep apnea","volume":"41","author":"Sands","year":"2018","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.conctc.2026.101660_bib51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1183\/09031936.00062914","article-title":"Quantifying the ventilatory control contribution to sleep apnoea using polysomnography","volume":"45","author":"Terrill","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.conctc.2026.101660_bib52","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"issue":"4","key":"10.1016\/j.conctc.2026.101660_bib53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/sim.3495","article-title":"A graphical approach to sequentially rejective multiple test procedures","volume":"28","author":"Bretz","year":"2009","journal-title":"Stat. Med."},{"issue":"6","key":"10.1016\/j.conctc.2026.101660_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bimj.201000239","article-title":"Graphical approaches for multiple comparison procedures using weighted bonferroni, simes, or parametric tests","volume":"53","author":"Bretz","year":"2011","journal-title":"Biom. J."},{"issue":"1","key":"10.1016\/j.conctc.2026.101660_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/19466315.2018.1562369","article-title":"Commentary on \u201cStatistics at Fda: reflections on the Past Six Years\u201d","volume":"11","author":"Bretz","year":"2019","journal-title":"Stat. Biopharm. Res."},{"issue":"2","key":"10.1016\/j.conctc.2026.101660_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/17407745231214382","article-title":"New strategies for confirmatory testing of secondary hypotheses on combined data from multiple trials","volume":"21","author":"Vandemeulebroecke","year":"2024","journal-title":"Clin. Trials"},{"issue":"6","key":"10.1016\/j.conctc.2026.101660_bib57","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.conctc.2026.101660_bib58","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N. Engl. J. Med."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:52:47Z","timestamp":1785912767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865426000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S2451865426000670"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101660","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101660"}}